B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax

Anna ChristoforidouDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, GreeceCorrespondence[email protected]

Zoe BezirgiannidouDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece

George VrachioliasDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece

Menelaos PapoutselisDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece

Emmanouil SpanoudakisDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece

Ιoannis KotsianidisDepartment of Haematology, Democritus University of Thrace, Alexandroupolis, Greece

Click to increase image sizeClick to decrease image size

Acknowledgements

We would like to thank Dr. Anastasia Athanasiadou for her dedicated work on performing karyotype of lymphoid malignancies.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax

Information for

Open access

Opportunities

Help and information

B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax

Acknowledgements

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature